Impact of axillary lymph node dissection on breast cancer outcome in clinically node negative patients

Cancer

Volumn 115, Issue 8, 2009, Pages 1613-1620

  Sanghani, Mona ^a   Balk, Ethan M ^a   Cady, Blake ^b  

^a TUFTS MEDICAL CENTER   (United States)

^b CAMBRIDGE HOSPITAL   (United States)

Author keywords

Axillary dissection; Breast cancer; Radiation therapy; Recurrence; Survival

Indexed keywords

TAMOXIFEN;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE IRRADIATION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; META ANALYSIS; OVERALL SURVIVAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; SURVIVAL TIME; SYSTEMATIC REVIEW;

AXILLA; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; EARLY DETECTION OF CANCER; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC IRRADIATION; LYMPHATIC METASTASIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; SURVIVAL ANALYSIS;

EID: 65249146115     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24174     Document Type: Article

References (12)

1. Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wol- mark N. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002; 347:567-575.
2. Orr RK. The impact of prophylactic axillary node dissection on breast cancer survival-a Bayesian meta-analysis. Ann Surg Oncol. 1999;6:109-116.
3. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
4. Martelli G, Boracchi P, De Palo M, et al. A randomized trial comparing axillary dissection to no axillary dissection in older patients with T1N0 breast cancer: results after 5 years of follow-up. Ann Surg. 2005;242:1-6.
5. Rudenstam CM, Zahrieh D, Forbes JF, et al. Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93. J Clin Oncol. 2006;24:337-344.
6. Louis-Sylvestre C, Clough K, Asselain B, et al. Axillary treatment in conservative management of operable breast cancer: dissection or radiotherapy? Results of a randomized study with 15 years of follow-up. J Clin Oncol. 2004;22:97-101.
7. Veronesi U, Orecchia R, Zurrida S, et al. Avoiding axillary dissection in breast cancer surgery: a randomized trial to assess the role of axillary radiotherapy. Ann Oncol. 2005;16:383-388.
8. Cabanes PA, Salmon RJ, Vilcoq JR, et al. Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. The Breast Carcinoma Collaborative Group of the Institut Curie. Lancet. 1992;339:1245-1248.
9. Reznik J, Cicchetti MG, Degaspe B, Fitzgerald TJ. Analysis of axillary coverage during tangential radiation therapy to the breast. Int J Radiat Oncol Biol Phys. 2005;61:163-168.
10. Wong JS, Recht A, Beard CJ, et al. Treatment outcome after tangential radiation therapy without axillary dissection in patients with early-stage breast cancer and clinically negative axillary nodes. Int J Radiat Oncol Biol Phys. 1997;39:915-920.
11. Coburn NG, Chung MA, Fulton J, Cady B. Decreased breast cancer size, stage, and mortality in Rhode Island: an example of a well-screened population. Cancer Control. 2004;11:222-230.
12. Chen SL, Hoehne FM, Giuliano AE. The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis. Ann Surg Oncol. 2007;14:3378-3384.